Sofinnova Investments, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001631134

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2024 · 60 positions · Total reported value $1.33B · Top-10 concentration 58.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 67.1% · 13 new · 16 cut · 26 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 98.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $2.38B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2024 13F filing, Sofinnova Investments, Inc. disclosed 60 equity positions with a combined reported value of $1.33B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.7% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were NTRA ($245.41M), VERA ($118.16M), GILD ($71.52M). By sector, the heaviest allocations are Health Care 93.0%, Industrials 0.5%. Versus the prior quarter, allocation shifted toward Health Care (+1.0pp) and away from Other (-1.2pp).

Versus the prior quarter, Sofinnova Investments, Inc. opened 13 new positions, trimmed 16 and fully exited 26, a turnover rate of 67.1% of positions. The portfolio's overlap with the prior quarter was 57% of names.

The largest new positions opened in Q4 2024 were GILD ($71.52M), ABBV ($63.86M), SRPT ($52.13M).

Of the 26 positions fully exited versus the prior quarter, the largest were NVO ($86.48M), ELAN ($51.69M), NVS ($23.00M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • GILD GILEAD SCIENCES INC · $71.52M
  • ABBV ABBVIE INC · $63.86M
  • SRPT SAREPTA THERAPEUTICS INC · $52.13M
  • SYK STRYKER CORPORATION · $41.77M
  • ALNY ALNYLAM PHARMACEUTICALS INC · $25.92M
  • ALKS ALKERMES PLC · $25.72M
  • DXCM DEXCOM INC · $22.57M
  • GMED GLOBUS MED INC · $20.24M

Fully Exited (vs previous quarter)

  • NVO NOVO-NORDISK A S · prev qtr: $86.48M
  • ELAN ELANCO ANIMAL HEALTH INC · prev qtr: $51.69M
  • NVS NOVARTIS AG · prev qtr: $23.00M
  • GH GUARDANT HEALTH INC · prev qtr: $9.33M
  • RVMD REVOLUTION MEDICINES INC · prev qtr: $9.22M
  • TGTX TG THERAPEUTICS · prev qtr: $8.39M
  • MRNS MARINUS PHARMACEUTICALS INC · prev qtr: $7.72M
  • CABA CABALETTA BIO INC · prev qtr: $7.24M

Insider Transactions (Form 4)

Latest Sofinnova Investments, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sofinnova Investments, Inc., based in Menlo Park, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 56 positions worth $1.88B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MENLO PARK, CA, United States
  • SEC registration: 801-110134 (status: Approved), registered 2017-03-22
  • Regulatory AUM (Form ADV): $5.37B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 3 hedge funds
  • Website: sofinnova.com

Portfolio Structure

  • 56 positions · $1.88B reported value (Q2 2026)
  • Top 10 holdings = 59.2% of reported value
  • Largest position: NTRA (NATERA INC) at 22.4%
  • Average position size: $33.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 16 reduced, 26 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 93.0%
Other 6.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.55M $245.41M 18.43%
18.43%
Hold
2 2.79M $118.16M 8.88%
8.88%
Hold
3 774.23K $71.52M 5.37%
5.37%
New
4 359.39K $63.86M 4.80%
4.80%
New
5 504.19K $62.09M 4.66%
4.66%
Add
6 428.77K $52.13M 3.92%
3.92%
New
7 1.70M $45.20M 3.40%
3.40%
Hold
8 651.34K $42.68M 3.21%
3.21%
Reduce
9 116.00K $41.77M 3.14%
3.14%
New
10 3.15M $38.14M 2.87%
2.87%
Add
11 524.27K $36.21M 2.72%
2.72%
Reduce
12 2.00M $35.40M 2.66%
2.66%
Hold
13 757.25K $34.04M 2.56%
2.56%
Add
14 346.57K $30.96M 2.33%
2.33%
Add
15 1.07M $27.48M 2.06%
2.06%
Reduce
16 110.16K $25.92M 1.95%
1.95%
New
17 894.27K $25.72M 1.93%
1.93%
New
18 1.07M $25.24M 1.90%
1.90%
Add
19 290.21K $22.57M 1.70%
1.70%
New
20 397.43K $22.25M 1.67%
1.67%
Add
21 244.70K $20.24M 1.52%
1.52%
New
22 37.90K $19.78M 1.49%
1.49%
New
23 256.28K $17.69M 1.33%
1.33%
Reduce
24 2.19M $17.18M 1.29%
1.29%
Hold
25 5.47M $16.80M 1.26%
1.26%
Reduce
26 253.26K $13.56M 1.02%
1.02%
Add
27 2.30M $13.35M 1.00%
1.00%
Hold
28 4.28M $11.86M 0.89%
0.89%
Hold
29 14.36K $11.09M 0.83%
0.83%
New
30 402.77K $10.75M 0.81%
0.81%
Add
31 560.72K $10.75M 0.81%
0.81%
Reduce
32 3.76M $9.96M 0.75%
0.75%
Hold
33 180.46K $9.21M 0.69%
0.69%
Add
34 658.63K $8.71M 0.65%
0.65%
Reduce
35 100.00K $8.46M 0.64%
0.64%
Reduce
36 527.19K $8.12M 0.61%
0.61%
Reduce
37 746.82K $7.93M 0.60%
0.60%
Add
38 823.16K $6.42M 0.48%
0.48%
Reduce
39 1.31M $4.60M 0.34%
0.34%
Reduce
40 1.80M $4.51M 0.34%
0.34%
Reduce
41 95.31K $4.39M 0.33%
0.33%
Reduce
42 200.00K $4.21M 0.32%
0.32%
New
43 40.00K $2.96M 0.22%
0.22%
Reduce
44 52.04K $2.92M 0.22%
0.22%
Add
45 343.21K $2.44M 0.18%
0.18%
Reduce
46 10.00K $2.30M 0.17%
0.17%
New
47 2.67M $2.06M 0.15%
0.15%
Hold
48 132.93K $1.76M 0.13%
0.13%
New
49 95.38K $1.51M 0.11%
0.11%
New
50 2.75M $1.47M 0.11%
0.11%
Hold

FAQ

What did Sofinnova Investments, Inc. buy in 2024-Q4?

In its 2024-Q4 13F filing, Sofinnova Investments, Inc. reported 60 equity positions worth $1.33B in aggregate; its largest disclosed positions were NTRA ($245.41M), VERA ($118.16M), GILD ($71.52M).

How large is Sofinnova Investments, Inc.'s portfolio?

Sofinnova Investments, Inc. reported $1.33B of long equity holdings across 60 positions as of 2024-Q4. Top-10 holdings account for 58.7% of reported value.

What is Sofinnova Investments, Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sofinnova-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →